baber/WOPTO huggingface dataset:
Patent FI-945071-A0 (FI)
Inventor: WALKER LINDA A
IPC: B65D55/02
Filed: 1994-10-27
Abstract: The bottle has a neck defining an opening at one end and a body having a recessed portion at the end opposite the opening. The recessed portion has a plurality of ramps disposed about its perimeter, the bottle having a thread disposed on the neck. A press-and-turn type cap has an inner shell engageable with the thread and an outer shell engaging with the inner shell by a press-and-turn device. The outer shell having a plurality of ramps disposed about the perimeter of the side. The ramps are disposed on the cap facing opposite the ramps disposed on the bottle. The ramps on the cap face in a counterclockwise direction and ramps on the bottle face in a clockwise direction. The bottle is cylindrical. The ramps are completely disposed about the perimeter of the bottle and cap and are intermittently disposed about the perimeter of the bottle and cap.
Patent FI-960465-A0 (FI)
Inventor: BULL JAMES RONALD
IPC: C07J1/00
Filed: 1996-02-01
Abstract: New 15,15-dialkyl-substituted derivatives of the estradiol of general formula I    <IMAGE>  (I)  in which R1 and R2, independently of one another, are each a hydrogen atom or a straight-chain alkanoyl group with 1 to 10 carbon atoms, a branched-chain alkanoyl group with 3-10 carbon atoms, an alkanoyl group of 3-10 carbon atoms containing a cycloaliphatic structure of 3-6 carbon ring atoms or a benzoyl group, and R3 and R4, independently of one another, are each a straight-chain alkyl group with 1 to 10 carbon atoms or a branched-chain alkyl group with 3 to 10 carbon atoms, are described, a process for their production and initial products for this process. The new compounds have-also after oral administration-high estrogenic effectiveness and are suitable for the production of pharmaceutical agents.
Patent FI-961286-A0 (FI)
Inventor: CARLSMITH LAWRENCE ALLAN
IPC: D21B1/16
Filed: 1996-03-20
Abstract: An apparatus produces elongate multi-fiber particles of extremely small size to facilitate substantially complete penetration of high consistency pulp fibers by ozone when exposed thereto. A housing is provided having first and second ends and a substantially smooth interior housing surface. A means is provided for introducing high consistency wood pulp into the housing. A source of ozone gas bleaches the high consistency pulp within the housing. A pin rotor is rotatably mounted within the housing, and includes a plurality of pins, each pin having a pin tip. A means is provided means for limiting the build up of high consistency pulp fiber accretions on the pin tips.
Patent FI-970283-A0 (FI)
Inventor: AULANKO ESKO
IPC: H02K7/10
Filed: 1997-01-23
Abstract: An elevator drive machine includes a traction sheave and an electromechanical apparatus having at least two electric motors for driving the traction sheave. The traction sheave and the weight applied to it via the elevator ropes are supported by bearings between the stators and rotors of the electric motors driving the traction sheave of the drive machine.
Patent FI-972545-A0 (FI)
Inventor: LINDBLAD MARINA
IPC: B01J23/40
Filed: 1997-06-16
Abstract: A catalyst with a high sulphur tolerance for the hydrogenation of middle distillate aromatics which comprises as a support (a) an alumina, the surface of which has been modified by contacting it with a silicon-containing compound, or (b) a silica, the surface of which has been modified by contacting it with an aluminum-containing compound. The support has been treated with air, oxygen or water vapor at an elevated temperature in order to convert the said silicon-containing compound or the said aluminum-containing compound to oxide form. The hydrogenating component of the catalyst is one or more metals of the platinum group.
Patent AP-9901635-A0 (AP)
Title: Anti-convulsant isoquinolyl-benzamide derivatives.
Inventor: HARLING JOHN DAVID
IPC: A61K31/472
Filed: 1998-03-16
Abstract: Compounds of formula (i)and pharmaceutically acceptable salts thereof, where r1 is hydorgen, c1-6 alkyl (optionally substituted by hydroxy or c1-4alkoxy), c1-6alkenyl, c1-6alkynyl, c1-6alkylco-,formyl, cf3co- or c1-6alkylso2-; r2 is hydrogen or up ot three substituents selected from halogen, no2, cn, n3, cf3o-, cf3s-, c3co-, trifluoromethyldiazirinyl, c?1-6?alkyl, c1-6alkenyl, c1-6alkynyl, c1-6perfluoroalkyl, c3-6cycloalkyl, c3-6cycloalkyl-c1-4alkyl-, c1-6alkylo-, c1-6alkylco-, c3-6cycloalkylo-, c3-6cycloalkylco-,c3-6cycloalkyl-c1-4alkylo-, c3-6cycloalkyl-c1-alkylco-, phenyl, phenoxy, benzyloxy, benzoyl, phenyl-c1-4alkyl-, c1-6alkyls-, c1-6alkylso2-, (c1-4alkyl)2nso2-, (c1-4alkyl)nhso2-, (c1-4alkyl)2nco-,(c1-4alkyl)nhco- or conh2; or -nr5r6 where r5 is hydrogen of c1-4alkyl, and r6 is hydrogen, c1-4alkyl, formyl, -co2c1-4alkyl or -coc1-4alkyl; or two r2 groups together form a carbocyclic ring that is saturated or unsaturated and unsubstituted or substituted or substituted by -oh or =o; and two groups and the two r4 groups are each independently hydrogen or c1-6alkyl or the two r3 groups and/or the twor4 groups together form a c3-6spiroalkyl group provided that at least one r3 and r4 group is not hydorgen, are useful in the treatment and prophylaxis of epilepsy and other disorders.
Patent IL-59330-A0 (IL)
Title: Process and intermediates for preparing benzazepine derivatives
IPC: C07C49/813
Filed: 1980-02-06
Abstract: 1. Claims for the Contracting States : BE, CH, DE, FR, GB, IT, LU, NL, SE Compounds of the general formula  see diagramm : EP0052599,P6,F2  wherein X and Y each signify hydrogen, halogen with an atomic number of at most 35 or trifluoromethyl and Z signifies hydroxy, methanesulphonyloxy, toluenesulphonyloxy, bromine or chlorine. 1. Claims for the Contracting State : AT A process for the manufacture of propargyl derivatives of the general formula  see diagramm : EP0052599,P6,F1  wherein X and Y each signify hydrogen, halogen with an atomic number of at most 35 or trifluoromethyl and Z signifies hydroxy, methanesulphonyloxy, toluenesulphonyloxy, bromine or chlorine, characterized by reacting a compound of the general formula  see diagramm : EP0052599,P6,F3  wherein X and Y have the above significance, with propargyl alcohol in the presence of a palladium (II) salt, an organophosphine, a tertiary or secondary amine and of copper (I) iodide and, if desired, converting the resulting compound of formula I in which Z signifies hydroxy into a compound of formula I in which Z signifies methanesulphonyloxy, toluenesulphonyloxy, bromine or chlorine.
Patent IL-71325-A0 (IL)
Title: Preparation of a fine crystalline form of isoxicam
IPC: C07D275/06
Filed: 1984-03-23
Abstract: A new process for the preparation of microcrystalline isoxicam having a particle size of about 1-30  mu m which comprises dissolving isoxicam in a mixture consisting of a solvent miscible with water and of an aqueous base where the resulting basic solution is neutralized with dilute acid to a pH of 4-6 with vigorous agitation precipitating the microcrystalline product is herein described.
Patent IL-80932-A0 (IL)
Title: Production of thrombin inhibitors
IPC: C12N15/15
Filed: 1986-12-10
Abstract: A method for the production and secretion of proteins with hirudin activity in an eukaryotic host organism is provided. There are also provided hybrid vectors comprising a DNA sequence encoding a signal peptide upstream of and in reading frame with the structural gene for desulphatohirudin, and eukaryotic host organisms transformed with said hybrid vectors.
Patent IL-89864-A0 (IL)
Title: Alkyl-and alkenylsulfonylureas which are substituted in the heterocycle,processes for their preparation,and their use as herbicides or plant growth regulators
IPC: A01N47/36
Filed: 1989-04-06
Abstract: Compounds of the formula I, their stereoisomers or their salts <IMAGE> (I)  wherein A denotes >C(R4)2 or >C=C(R5)2; R1 denotes H, an optionally substituted aliphatic or cycloaliphatic radical, forfuryl, tetrahydrofurfuryl or (substituted) phenyl; R2 denotes H, alkyl, alkenyl, alkynyl or alkoxy; R3 denotes a radical of the formulae <IMAGE>  <IMAGE>  <IMAGE> +TR  <IMAGE>  X denotes O, S or NR12 and Y denotes O or S, possess excellent herbicidal and plant-growth regulating properties.
Patent IL-92521-A0 (IL)
Title: Acrylic precursor for carbon fibres and method for its preparation
IPC: D01F6/18
Filed: 1989-12-01
Abstract: A method for preparing acrylic precursors with improved characteristics suitable for transformation into carbon fibres of superior mechanical characteristics comprises wet-spinning an acrylic polymer dissolved in dimethylacetamide followed by coagulation in a solvent-non solvent binary mixture bath of rigorously controlled composition and temperature, and a series of controlled-condition stretching operations with interposed washing stages, followed by yarn drying before its final collection. The method is characterised essentially by its coagulation stage, which is conducted under such rigorously controlled bath temperature and composition conditions as to obtain at the end of the process an acrylic yarn which has a perfectly compact structure practically free of flaws (voids), a perfectly circular cross-section and mechanical characteristics which are distinctly better than those of acrylic yarns of identical composition obtained by spinning processes of the known art. The specific destination of the acrylic yarn is the production of high-performance carbon fibres.
Patent IL-96486-A0 (IL)
Title: Tricyclic compounds,their preparation and pharmaceutical compositions containing them
IPC: C07D453/06
Filed: 1990-11-27
Abstract: The present invention is directed to new pharmaceutically active compounds with 5-HT3 receptor antagonist activity of Formula I: <CHEM>  in which  the dashed line denotes an optional double bond;  n is 1, 2 or 3;  p is 0, 1, 2 or 3;  q is 0, 1 or 2; each R<1> is halogen, hydroxy, alkoxy (optionally substituted with phenyl), alkyl, nitro, amino, amino carbonyl, (alkyl)amino, di(alkyl)amino, and (alkanoyl)amino;  each R<2> is alkyl; and  R<3> is <CHEM>    in which  u, x, y, and z are all independently an integer from 1 to 3; and R<4> and R<5> are independently alkyl, cycloalkyl, cycloalkylalkyl, or a group (CH2)tR6 where t is 1 or 2 and R6 is thienyl, pyrrolyl or furyl optionally further substituted by one or two substituents selected from alkyl, alkoxy, trifluoromethyl or halogen, or is phenyl optionally substituted by alkoxy, trifluoromethyl, halogen, nitro, carboxy, esterified carboxy, and alkyl (optionally substituted).
Patent FI-20002477-A0 (FI)
Inventor: YLOENEN TATU
IPC: H04L29/08
Filed: 2000-11-13
Abstract: A method is provided for intercepting network packets in a computer system, where a number of functions are used to communicate network packets between a network adapter and a protocols entity. A first network adapter and a first protocols entity installed in the computer system are identified. A set of replacement functions is provided within a packet interceptor module. At least one function used for transmitting network packets from said first protocols entity to said first network adapter is hooked into a first replacement function. At least one function used for transmitting network packets from said first network adapter to said first protocols entity is hooked into a second replacement function. At least one function used for receiving information about the status of the network interface implemented by said first network adapter is hooked into a third replacement function.
Patent FI-20030264-A0 (FI)
IPC: E21B45/00
Filed: 2003-02-21
Abstract: The invention relates to a telescopic feed beam for a rock drill and to a method of measuring a travel length. The pressure surface of a piston (11b) in a feed cylinder (11) of the feed beam is twice as large as the pressure surface of a piston (6b) in a feed extension cylinder (6). Furthermore, the feed beam comprises a flow indicator (19) for measuring the volume flow rate of hydraulic fluid fed and/or discharged, and thereby the travel length.
Patent FI-20055502-A0 (FI)
Inventor: LEVANDER OSKAR
IPC: B63B/
Filed: 2005-09-20
Abstract: The invention relates to a marine vessel with at least a first cargo facility at a stern end and at least a second cargo facility at a bow end, and having a deckhouse arranged between the first cargo facility and the second cargo facility. In order to provide for cost-effective propulsion and cargo transport in combination, the propulsion system comprises a first propulsion unit and a second propulsion unit forming a CRP propulsion system. The machinery of the first propulsion unit and the machinery of the second propulsion unit are located on top of each other under the deckhouse.
Patent IL-105358-A0 (IL)
Title: Corneal dissector blade assembly
IPC: A61F2/14
Filed: 1993-04-09
Abstract: A single bladed dissector blade assembly suitable for forming a generally circumcorneal interlamellar channel in an eye, comprising:   a blade having a dissecting end, a support end, and a cross-section, said blade being in the form of a major arc in a plane perpendicular to a rotational axis thereof; and a blade support arm having a first end and a second end, said first end of said support being attached at one end to the support end of the blade.   <IMAGE>
Patent IL-106597-A0 (IL)
Title: Androst-4-eno(4,5-b)pyrrole derivatives,their preparation and pharmaceutical compositions containing them
IPC: C12N9/99
Filed: 1993-08-05
Abstract: This invention refers to compounds of formula (I) or double bonds; R is hydrogen or C1-C4 alkyl; R1 is hydrogen or an acyl group; R2 is hydrogen; C1-C4 alkyl unsubstituted or substituted by phenyl; phenyl unsubstituted or substituted by C1-C4 alkyl or C1-C4 alkoxy; and A is a >C=O, >CH OH or >CH OR3 group, in which R3 is an acyl group provided that one of z and y is a double bond and the other is a single bond. The compounds are useful as aromatase inhibitors.
Patent IL-113631-A0 (IL)
Title: New antagonist compounds
IPC: C07D489/09
Filed: 1995-05-07
Abstract: PCT No. PCT/SE95/00503 Sec. 371 Date Aug. 22, 1995 Sec. 102(e) Date Aug. 22, 1995 PCT Filed May 9, 1995 PCT Pub. No. WO95/31463 PCT Pub. Date Nov. 23, 1995New morphinane derivatives of the formula their pharmaceutically acceptable salts, a process for their preparation and their use in the manufacture of pharmaceutical preparations.
Patent IL-114830-A0 (IL)
Title: Polyspecific immunoconjugates and antibody composites
IPC: A61K38/00
Filed: 1995-08-03
Abstract: Polyspecific immunoconjugates and antibody composites that bind a multidrug transporter protein and an antigen associated with a tumor or infectious agent are used to overcome the multidrug resistant phenotype. These immunoconjugates and composites also can be used diagnostically to determine whether the failure of traditional chemotherapy is due to the presence of multidrug resistant tumor cells, multidrug resistant HIV-infected cells or multidrug resistant infectious agents.
Patent IL-121185-A0 (IL)
Title: Plastics articles
IPC: C08J9/08
Filed: 1996-06-17
Abstract: PCT No. PCT/GB96/01434 Sec. 371 Date Aug. 13, 1997 Sec. 102(e) Date Aug. 13, 1997 PCT Filed Jun. 17, 1996 PCT Pub. No. WO97/15627 PCT Pub. Date May 1, 1997A foamed polyester resin article is made by a method which includes forming a molten resin mixture containing poly (ethylene terephthalate) having an intrinsic viscosity greater than 0.7 and a moisture content of not greater than 0.03%, a melt viscosity modifier which comprises a multi-stage emulsion graft copolymer of methyl methacrylate and a lower alkyl acrylate monomer, and a heat activatable decomposition-type foaming agent. The mixture is heated in the barrel of an extruder and extruded through the die of the extruder. The method can be used to produce extruded poly (ethylene terephthalate) sheet having a foamed structure suitable for subsequent thermoforming into packaging articles and food containers such as those used in dualovenable food trays used for reheating foods in microwave or conventional ovens. The articles produced by the method have a density which may be 35-40% less than that of similar articles made from conventional non-foamed poly (ethylene terephthalate).
Patent IL-123490-A0 (IL)
Title: Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities
IPC: C07C/
Filed: 1996-08-23
Abstract: The invention provides a compound of the formula <CHEM>     wherein X is S, O, NR' where R' is H or alkyl of 1 to 6 carbons, or   X is ÄC(R1)2Ün where R1 is independently H or alkyl of 1 to 6 carbons, and n is an integer between 0 and 2; R2 is hydrogen, lower alkyl of 1 to 6 carbons, F, Cl, Br, I, CF3, fluoro substituted alkyl of 1 to 6 carbons, OH, SH, alkoxy of 1 to 6 carbons, or alkylthio of 1 to 6 carbons;   R3 is hydrogen, lower alkyl of 1 to 6 carbons or F;   m is an integer having the value 0-3;   o is an integer having the value 0-3; Y is a phenyl or naphthyl group, or heteroaryl selected from a group consisting of pyridyl, thienyl, furyl, pyridazinyl, pyrimidinyl, pyrazinyl, thiazolyl, oxazolyl, imidazolyl and pyrrazolyl, said phenyl and heteroaryl groups being optionally substituted with one or two R2 groups; A is (CH2)q where q is 0-5, lower branched chain alkyl having 3-6 carbons, cycloalkyl having 3-6 carbons, alkenyl having 2-6 carbons and 1 or 2 double bonds, alkynyl having 2-6 carbons and 1 or 2 triple bonds; B is hydrogen, COOH or a pharmaceutically acceptable salt thereof, COOR8, CONR9R10, -CH2OH, CH2OR11, CH2OCOR11, CHO, CH(OR12)2, CHOR13O, -COR7, CR7(OR12)2, CR7OR13O, or tri-lower alkylsilyl, where R7 is an alkyl, cycloalkyl or alkenyl group containing 1 to 5 carbons, R8 is an alkyl group of 1 to 10 carbons or trimethylsilylalkyl where the alkyl group has 1 to 10 carbons, or a cycloalkyl group of 5 to 10 carbons, or R8 is phenyl or lower alkylphenyl, R9 and R10 independently are hydrogen, an alkyl group of 1 to 10 carbons, or a cycloalkyl group of 5-10 carbons, or phenyl or lower alkylphenyl, R11 is lower alkyl, phenyl or lower alkylphenyl, R12 is lower alkyl, and R13 is divalent alkyl radical of 2-5 carbons, and R14 is (R15)r-phenyl, (R15)r-naphthyl, or (R15)r-heteroaryl where the heteroaryl group has 1 to 3 heteroatoms selected from the group consisting of O, S and N, r is an integer having the values of 0-5, and R15 is independently H, F, Cl, Br, I, NO2, N(R8)2, N(R8)COR8, NR8CON(R8)2, OH, OCOR8, OR8, CN, an alkyl group having 1 to 10 carbons, fluoro substituted alkyl group having 1 to 10 carbons, an alkenyl group having 1 to 10 carbons and 1 to 3 double bonds, alkynyl group having 1 to 10 carbons and 1 to 3 triple bonds, or a trialkylsilyl or trialkylsilyloxy group where the alkyl groups independently have 1 to 6 carbons;   R16 is H, lower alkyl of 1 to 6 carbons;   R17 is H, lower alkyl of 1 to 6 carbons, OH or OCOR11, and p is zero or 1, with the proviso that when p is 1 then there is no R17 substituent group, and m is an integer between 0 and 2.
Patent IL-144058-A0 (IL)
Title: Composition for coating fruits, vegetables and fowl eggs, especially useful for organic produce
IPC: A23L15/00
Filed: 2001-06-28
Abstract: The invention relates to a composition for coating fruits, vegetables, fowl eggs, and especially for organically-grown produce for protection and extension of the shelf life of said fruits, vegetables and fowl eggs, wherein said composition is an aqueous dispersion comprised of: (a) a hydrophobic component comprising at least one member of the following group consisting of natural wax, or vegetable oil; (b) an alkali agent; (c) water, wherein components (a) and (b) are derived from natural biological sources. The invention also relates to a method for application of the composition.
Patent IL-160052-A0 (IL)
Title: Diagnostic and pharmaceutical compositions containing microorganisms or cells including a detectable protein
IPC: G01N33/574
Filed: 2002-07-31
Abstract: Described are diagnostic and pharmaceutical compositions comprising a microorganism or cell containing a DNA sequence encoding a detectable protein or a protein capable of inducing a detectable signal, e.g. a luminescent or fluorescent protein. Moreover, the use of said microorganism or cell for tumor-targeting or tumor-imaging is described. For therapeutic uses, said microorganism or cell additionally contain an expressible DNA sequence encoding a protein suitable for tumor therapy, e.g. a cytotoxic or cytostatic protein.
Patent IL-165267-A0 (IL)
Title: Selected antibodies and duramycin peptides bindingto anionic phospholipids and aminophospholipids and their use in treating viral infections and cancer
IPC: A61P27/06
Filed: 2003-07-15
Abstract: Disclosed are surprising discoveries concerning the role of anionic phospholipids and aminophospholipids in tumor vasculature and in viral entry and spread, and compositions and methods for utilizing these findings in the treatment of cancer and viral infections. Also disclosed are advantageous antibody, immunoconjugate and duramycin-based compositions and combinations that bind and inhibit anionic phospholipids and aminophospholipids, for use in the safe and effective treatment of cancer, viral infections and related diseases.
Patent IL-166254-A0 (IL)
Title: Novel quinuclidine derivatives and their use
IPC: A61K31/501
Filed: 2005-01-12
Abstract: This invention relates to novel quinuclidine derivatives and their use as pharmaceuticals. Due to their pharmacological profile the compounds of the invention may be useful for the treatment of diseases or disorders as diverse as those related to the cholinergic system of the central nervous system (CNS), the peripheral nervous system (PNS), diseases or disorders related to smooth muscle contraction, endocrine diseases or disorders, diseases or disorders related to neuro-degeneration, diseases or disorders related to inflammation, pain, and withdrawal symptoms caused by the termination of abuse of chemical substances.
Patent IL-173183-A0 (IL)
Title: Protein purification by ion exchange chromatography
IPC: C07K16/32
Filed: 2006-01-17
Abstract: A method for purifying a polypeptide by ion exchange chromatography is described which involves changing the conductivity and/or pH of buffers in order to resolve a polypeptide of interest from one or more contaminants.
Patent IL-173822-A0 (IL)
Title: Use of oxcarbazepine for the treatment of diabetic neuropathic pain and the improvement of sleep
IPC: A61K31/55
Filed: 2006-02-20
Abstract: The present invention provides for novel uses of the carbamazepine derivative of formula (I) and its pharmaceutically acceptable salts, in particular an improved regiment for the administration of the carbamazepine derivative of formula (I) and the pharmaceutically acceptable salts thereof for the treatment of patients suffering from pin, in particular neuropathic paid, and the improvement of sleep; the use of oxcarbazepine for the manufacture of a pharmaceutical composition for the treatment of pain or the manufacture of a pharmaceutical composition for the improvement of sleep in human patients suffering from chronic pain; pharmaceutical composition comprising oxcarbazepine as sole active ingredient for the treatment of pain or for the improvement of sleep in human patients suffering from chronic pain and to packages comprising a pharmaceutical composition comprising as sole active ingredient oxcarbazepine together with instructions for the treatment of pain or together with instructions for improvement of sleep in human patients suffering from chronic pain.